Author

Stephanie Adel Haddad

Observed name: S. Haddad

Institutions: The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio

Observed institutions: The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio

OpenAlex ID: A5122823277

Abstract PD8-06: Real-world Analysis on the Impact of GLP-1 Receptor Agonists on All-cause Mortality and Endocrine Therapy-Tolerability in Obese Breast Cancer Patients

2026 · C. Jones, J. Michalek, et al. · Clinical Cancer Research · 2

Fezolinetant for the management of vasomotor symptoms in patients with breast cancer.

2026 · Stephanie Adel Haddad, Justin Horowitz, et al. · Journal of Clinical Oncology

Abstract PS1-05-28: Evaluating all-cause mortality and endocrine therapy tolerability with sodium glucose cotransporter-2 inhibitors in hormone receptor-positive breast cancer: A real-world analysis

2026 · C. Jones, J. Michalek, et al. · Clinical Cancer Research

Real-world analysis on the impact of GLP-1 receptor agonists on survival and metastatic risk in colorectal cancer.

2026 · Colton Jones, Ariana Neely, et al. · Journal of Clinical Oncology

Works count: 4

Citation count: 2

H-index: 1

I10-index: